Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

IBRXIBRX
Showing 8 of 22 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in IMMUNITYBIO INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 2.9M shares of IBRX (IMMUNITYBIO INC), worth $25.3M as of 2026-Q2. The position was increased (+16.6% shares). IBRX represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$25.3M

Current Shares

2.9M

Total Value Change

+$20.6M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.9M
+16.6%
$25.3M0.0%$8.76
33
2026-Q1
Decreased
2.5M
-0.9%
$19M0.0%$10.00
0
2025-Q4
Increased
2.5M
+8.8%
$5M0.0%$1.98
29
2025-Q3
Increased
2.3M
+29.5%
$5.7M0.0%$2.57
34
2025-Q2
Increased
1.8M
+36.4%
$4.7M0.0%$2.70
35
2025-Q1
Increased
1.3M
+2.0%
$3.9M0.0%$3.14
27
2024-Q4
Increased
1.3M
+0.8%
$3.3M0.0%$2.68
27
2024-Q3
Increased
1.3M
+2.4%
$4.7M0.0%$3.93
27

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used